Invitrogen™ 158P1D7 Biosimilar Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody

Product Code	Brand	Quantity
30284152	Invitrogen™ MA558975	100 μg
30284181	Invitrogen™ MA558976	1 mg

Description

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °. This antibody can also be cross referenced by the term Agensys patent anti-158P1D7.

The gene 158P1D7, also known as the gene encoding the pentadecapeptide BPC 157, is derived from a partial sequence of the body protection compound (BPC) found in human gastric juice. BPC 157 is composed of 15 amino acids and has been identified for its significant therapeutic effects on wound healing and tissue regeneration. It is particularly noted for its role in accelerating the healing of various types of wounds, including tendons and ligaments, due to its ability to promote angiogenesis and modulate the inflammatory response. Its mechanisms involve interactions with growth factors and cellular signaling pathways, making it a promising candidate for treating musculoskeletal injuries and disorders.

Specifications

• Antigen: 158P1D7 Biosimilar
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Classification: Recombinant Monoclonal
• Form: Lyophilized
• Isotype: IgG2SA
• Target Species: Human
• Primary or Secondary: Primary
• Purification Method: Protein A

• Concentration: 1 mg/mL
• Applications: ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
• Conjugate: Unconjugated
• Host Species: Human
• Regulatory Status: RUO
• Formulation: 25 mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
• Product Type: Antibody